About Katie Coltart
Katie Coltart is a partner in Kirkland’s London IP Litigation team. Katie focuses her practice on patent litigation, particularly in the life sciences and tech sectors. Katie is experienced in dealing with multi-jurisdictional cases requiring significant cross-border coordination across multiple forums at both first instance and on appeal.
Katie has litigated patents across a broad spectrum of technological subject matters including those relating to antibody and other protein biologics, biological product development and screening platforms, checkpoint inhibitor immunotherapies, diagnostics and next generation sequencing technologies, medical devices, wireless and mobile telecommunications, and consumer product technologies. With a degree in Natural Sciences (Chemistry and Biology) Katie is well placed to advise her life sciences clients on their most technical subject matter.
In addition to her patent practice, Katie also has experience dealing with trade secrets, trade mark, and IP licensing matters in the finance, media, and retail sectors.
‘Next Generation Partner’ for Intellectual Property by The Legal 500 (“experience way beyond her years”)
‘IP Trailblazer’ in World Intellectual Property Review’s Influential Women in IP 2019
WIPR Leader by World Intellectual Property Review
“Patent Litigation 2021: Trends and Developments”, Chambers and Partners Practice Guides, 2021
“Court on Camera”, World IP Review, April 2020
“Setting global licence rates for standard essential patents: will the UK take centre stage?”, Financier Worldwide Magazine, January 2020
UK Supreme Court Case Tracker: Unwired Planet v Huawei; Conversant v Huawei And ZTE, November 2019
“How to empower young IP lawyers to be leaders”, Managing Intellectual Property, July 2019
“Patent Litigation 2019: Trends and Developments”, Chambers and Partners Practice Guides, 2019